Updated Recommendation
A new evidence synthesis was published:2023, Mental Health Gap Action Programme (mhGAP) guideline for mental, neurological and substance use disorders, [3rd ed.].
View latest version (2023)Bibliographic information
Recommendation
(Psychosis including schizophrenia and bipolar disorder) In adolescents with psychotic disorders (including schizophrenia and bipolar disorder), certain second-generation antipsychotic medications (aripiprazole, olanzapine, quetiapine, risperidone, ziprasidone) can be offered as a treatment option under supervision of a specialist. If treatment with one of the above agents is not feasible, first-generation antipsychotics (haloperidol, chlorpromazine, perphenazine, molindone) may be used under supervision of a specialist
Recommended in favor
Conditional
Certainty of evidence
Very low